Home » Alternative medicine » A key health law question: Will superior costs rise or not?

A key health law question: Will superior costs rise or not?

Will the law cause insurance premiums to skyrocket, as Republicans vow, or does it slow costs down, as Democrats predict? . Related StoriesIdentifying obstructive coronary artery disease in females: an interview with Dr. Ladapo, NYU College of MedicineGood rest patterns are best for your heartRaising lupus awareness: an interview with Professor Ramsey-Goldman, MD In other news, The Wall Road Journal writes about an emerging market place entity that’s catching employees' interest – – the private wellness exchange. The Wall Street Journal: TO SAVE LOTS OF, Workers Take On Health-Price Risk Last fall, two big companies embarked on a radical new approach to employee health advantages, offering workers a amount of cash and allowing them to select their health plans on an online marketplace.Anderson, M.D., Michel Pontari, M.D., Daniel A. Shoskes, M.D., Tag S. Litwin, M.D., Richard B. Alexander, M.D., Paige C. White colored, M.D., Richard Berger, M.D., Robert Nadler, M.D., Michael O’Leary, M.D., Guys Long Liong, M.D., Scott Zeitlin, M.D., Shannon Chuai, Ph.D., J. Richard Landis, Ph.D., John W. Kusek, Ph.D., Leroy M. Nyberg, M.D., and Anthony J. Schaeffer, M.D.5,6 The prevalence price of physician-diagnosed prostatitis in one U.S. Community was 9 percent7; population-structured surveys of symptoms estimate the prevalence of prostatitis-like symptoms to be between 6 and 12 percent.8 In the majority of males whose symptoms persist for more than 3 months, the cause of symptoms is thought to be noninfectious.9 Despite too little supporting evidence from medical trials10-12 and the probability of a noninfectious cause,1,9 antimicrobial and antiinflammatory agents are often considered the mainstay of drug therapy because of this syndrome.2 The findings of several placebo-controlled trials,14-17 however, not all of them,11 claim that treatment with alpha-adrenergic receptor antagonists might be effective for reducing symptoms in men with this syndrome, especially in anyone who has not previously been treated with these drugs and who’ve had symptoms for a relatively short time .